Cargando…
Increased expression of miR‐641 contributes to erlotinib resistance in non‐small‐cell lung cancer cells by targeting NF1
Epidermal growth receptor (EGFR)‐targeted tyrosine kinase inhibitors (TKIs) have emerged as first‐line drugs for advanced non‐small‐cell lung cancer (NSCLC) patients with EFGR mutations. However, most patients with NSCLC show acquired resistance to EGFR‐TKIs, and low expression of NF1 is a mechanism...
Autores principales: | Chen, Juan, Cui, Jie‐da, Guo, Xiao‐tong, Cao, Xia, Li, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911582/ https://www.ncbi.nlm.nih.gov/pubmed/29493886 http://dx.doi.org/10.1002/cam4.1326 |
Ejemplares similares
-
Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015) -
Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2
por: Zhang, Fenghua, et al.
Publicado: (2020) -
LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR‐146a
por: Liu, Hong‐tao, et al.
Publicado: (2016) -
Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer
por: Watanabe, Kousuke, et al.
Publicado: (2015) -
Erlotinib induces the human non–small‐cell lung cancer cells apoptosis via activating ROS‐dependent JNK pathways
por: Shan, Fenglian, et al.
Publicado: (2016)